CS Genetics

CS Genetics is a privately held genomics-technology company developing transformative single-cell analysis tools designed to scale from pilot studies to population genomics. Founded in 2014 by Lucas Edelman and based in Cambridge, England (with a US office in San Diego, California), the company has pioneered a radically new, instrument-free approach to single-cell sequencing that uses chemical biology to index molecules across thousands of cells simultaneously. Its flagship product, the SimpleCell platform, enables complete single-cell RNA-seq experiments in a single day — accelerating discovery, reducing cost per sample, and eliminating batching complexity in a modular, automation-ready format that requires no custom hardware. The SimpleCell 3' Gene Expression Kits, launched in late 2024, are designed to make single-cell transcriptomics accessible to a broader range of research labs. CS Genetics is positioned to serve pharmaceutical, biotech, and academic research customers seeking high-throughput, cost-effective single-cell genomics solutions. Carolina Molecular has been named a certified service provider for the platform. The company is led by CEO Bill Colston, PhD, COO Jay Harger, PhD, and CSO Mike Stubbington, PhD.